TVD 2017

PET Impact: Staging & Management

Changes in XRT management (TVD, dose or therapy intent)

Diagnosis (Ca)

Case (N)

Mx Change (N)

Mx Change (%)

H & N

55 28 28 26 24 18

18

33 32 25 31 21 22 75 50

Gyn

9 7 8 5 4 3 1 0

Breast

Lung

Lymphoma

GI

Unknown Prim

4 2

Melanoma Other Ca

17

0

27

Total

202

55

Dizendorf et al. J Nuc Med 2003